This issue of PATH Today focuses on the launch of the MenAfriVac™ vaccine, the first meningitis vaccine created specifically for Africa. The issue includes a timeline of meningitis in Africa and the development of the vaccine, how PATH partnered with other organizations to create an affordable solution, and a glimpse of what life is like in the "meningitis belt."

Corporate author(s): PATH

Publication date: December 2010

Available materials


Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

This publication is part of the series PATH Today

Related regions: Global

See also: Vaccines and immunization > Meningitis

For more information…

Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA